178 related articles for article (PubMed ID: 20602631)
1. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631
[TBL] [Abstract][Full Text] [Related]
2. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
3. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
4. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Narasimhan M
J Neurol Sci; 2010 Oct; 297(1-2):11-4. PubMed ID: 20673919
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study.
Bril V; Hartung HP; Lawo JP; Durn BL; Mielke O
Clin Neurophysiol; 2021 Jan; 132(1):226-231. PubMed ID: 33039291
[TBL] [Abstract][Full Text] [Related]
7. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
9. Early axonal loss predicts long-term disability in chronic inflammatory demyelinating polyneuropathy.
Al-Zuhairy A; Jakobsen J; Krarup C
Clin Neurophysiol; 2021 Apr; 132(4):1000-1007. PubMed ID: 33581994
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Samarasekera S
Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy.
Clouston PD; Kiers L; Zuniga G; Cros D
Electroencephalogr Clin Neurophysiol; 1994 Aug; 93(4):245-54. PubMed ID: 7521284
[TBL] [Abstract][Full Text] [Related]
12. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.
Cleland JC; Logigian EL; Thaisetthawatkul P; Herrmann DN
Muscle Nerve; 2003 Aug; 28(2):189-93. PubMed ID: 12872323
[TBL] [Abstract][Full Text] [Related]
13. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
[TBL] [Abstract][Full Text] [Related]
14. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatment.
Pegat A; Boisseau W; Maisonobe T; Debs R; Lenglet T; Psimaras D; Azoulay-Cayla A; Fournier E; Viala K
J Peripher Nerv Syst; 2020 Jun; 25(2):162-170. PubMed ID: 32364302
[TBL] [Abstract][Full Text] [Related]
15. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy.
Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D
Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent conduction block in chronic inflammatory demyelinating polyneuropathy.
Straver DC; van den Berg LH; Franssen H
J Neurol Sci; 2011 Jan; 300(1-2):33-8. PubMed ID: 21035143
[TBL] [Abstract][Full Text] [Related]
17. Sensory pathophysiology in chronic acquired demyelinating neuropathy.
Krarup C; Trojaborg W
Brain; 1996 Feb; 119 ( Pt 1)():257-70. PubMed ID: 8624687
[TBL] [Abstract][Full Text] [Related]
18. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological patterns of diabetic polyneuropathy.
Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
